Potent bombesin antagonists with C-terminal Leu-ψ(CH2-N)-Tac-NH2 or its derivatives

R. Z. Cai, H. Reile, P. Armatis, Andrew V Schally

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Various pseudononapeptide bombesin (BN)-(6-14) antagonists with a reduced peptide bond (CH2-NH) between positions 13 and 14 can suppress the mitogenic activity of BN or gastrin-releasing peptide in 3T3 fibroblast cells and small cell lung carcinoma. In the search for more potent BN antagonists, 10 modified nonapeptide BN antagonists containing N-terminal D-Phe, D-Cpa, and D- or L-Tpi and C-terminal Leu-ψ(CH2-N)-Tac-NH2, Leu-ψ(CH2-N)-MeTac- NH2, or Leu-ψ(CH2-N)-Me2Tac-NH2 have been synthesized by incubating [13ψ14,CH2-NH,Cys14]BN-(6-14) or [13ψ14-CH2-NH,Pen14]BN-(6- 14) with formaldehyde or acetaldehyde (Cpa = 4-chlorophenylalanine, Tac = thiazolidine-4-carboxylic acid, Tpi = 2,3,4,9-tetrahydro-1H-pyrido[3,4- b]indol-3-carboxylic acid, and Pen = penicillamine). The biological activities of these compounds were then evaluated. [D-Phe6,13ψ14,CH2- N,Tac14]BN-(6-14) (RC-3950-II) and [D-Phe6,13ψ14,CH2- N,Me2Tac14]BN-(6-14) (RC-3985-II) exhibited greater potency in inhibition of 125I-labeled [Tyr4]BN binding to Swiss 3T3 cells than their parent compounds [D-Phe6,13ψ14,CH2-NH,Cys14]BN-(6-14) (RC-3950-I) and [D- Phe6,13ψ14,CH2-NH,Pen14]BN-(6-14) (RC-3985-I). The order of binding affinities of these compounds was as follows: [13ψ14,CH2-N,Tac14]BN- (6-14) > [13ψ14,CH2-N,Me2Tac14]BN-(6-14) > [13ψ14,CH2- N,MeTac14]BN-(6-14). In most cases, the analogs with C-terminal Leu- ψ(CH2-N)-Tac-NH2 were also more potent growth inhibitors of 3T3 cells than compounds containing C-terminal Leu-ψ(CH2-N)-Me2Tac-NH2 or Leu-ψ(CH2- N)-MeTac-NH2. The best BN antagonists of this series, RC-3950-II and [D- Cpa6,13ψ14,CH2-N,Tac14]BN-(6-14) (RC-3925-II), inhibited gastrin- releasing peptide-stimulated growth of Swiss 3T3 cells with IC50 values of 1 nM and 6 nM, respectively. Since antagonists of this class inhibit growth of various tumors in animal cancer models, some of them may have clinical applications.

Original languageEnglish
Pages (from-to)12664-12668
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume91
Issue number26
DOIs
StatePublished - Dec 20 1994
Externally publishedYes

Fingerprint

Bombesin
Swiss 3T3 Cells
Gastrin-Releasing Peptide
3T3 Cells
Growth Inhibitors
Penicillamine
Acetaldehyde
Small Cell Lung Carcinoma
Growth
Carboxylic Acids

Keywords

  • peptide receptors
  • peptide synthesis
  • pseudononapeptide analogs
  • tumor growth inhibition

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Potent bombesin antagonists with C-terminal Leu-ψ(CH2-N)-Tac-NH2 or its derivatives. / Cai, R. Z.; Reile, H.; Armatis, P.; Schally, Andrew V.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 91, No. 26, 20.12.1994, p. 12664-12668.

Research output: Contribution to journalArticle

@article{4c31daaebbbb432ba2852307930809b1,
title = "Potent bombesin antagonists with C-terminal Leu-ψ(CH2-N)-Tac-NH2 or its derivatives",
abstract = "Various pseudononapeptide bombesin (BN)-(6-14) antagonists with a reduced peptide bond (CH2-NH) between positions 13 and 14 can suppress the mitogenic activity of BN or gastrin-releasing peptide in 3T3 fibroblast cells and small cell lung carcinoma. In the search for more potent BN antagonists, 10 modified nonapeptide BN antagonists containing N-terminal D-Phe, D-Cpa, and D- or L-Tpi and C-terminal Leu-ψ(CH2-N)-Tac-NH2, Leu-ψ(CH2-N)-MeTac- NH2, or Leu-ψ(CH2-N)-Me2Tac-NH2 have been synthesized by incubating [13ψ14,CH2-NH,Cys14]BN-(6-14) or [13ψ14-CH2-NH,Pen14]BN-(6- 14) with formaldehyde or acetaldehyde (Cpa = 4-chlorophenylalanine, Tac = thiazolidine-4-carboxylic acid, Tpi = 2,3,4,9-tetrahydro-1H-pyrido[3,4- b]indol-3-carboxylic acid, and Pen = penicillamine). The biological activities of these compounds were then evaluated. [D-Phe6,13ψ14,CH2- N,Tac14]BN-(6-14) (RC-3950-II) and [D-Phe6,13ψ14,CH2- N,Me2Tac14]BN-(6-14) (RC-3985-II) exhibited greater potency in inhibition of 125I-labeled [Tyr4]BN binding to Swiss 3T3 cells than their parent compounds [D-Phe6,13ψ14,CH2-NH,Cys14]BN-(6-14) (RC-3950-I) and [D- Phe6,13ψ14,CH2-NH,Pen14]BN-(6-14) (RC-3985-I). The order of binding affinities of these compounds was as follows: [13ψ14,CH2-N,Tac14]BN- (6-14) > [13ψ14,CH2-N,Me2Tac14]BN-(6-14) > [13ψ14,CH2- N,MeTac14]BN-(6-14). In most cases, the analogs with C-terminal Leu- ψ(CH2-N)-Tac-NH2 were also more potent growth inhibitors of 3T3 cells than compounds containing C-terminal Leu-ψ(CH2-N)-Me2Tac-NH2 or Leu-ψ(CH2- N)-MeTac-NH2. The best BN antagonists of this series, RC-3950-II and [D- Cpa6,13ψ14,CH2-N,Tac14]BN-(6-14) (RC-3925-II), inhibited gastrin- releasing peptide-stimulated growth of Swiss 3T3 cells with IC50 values of 1 nM and 6 nM, respectively. Since antagonists of this class inhibit growth of various tumors in animal cancer models, some of them may have clinical applications.",
keywords = "peptide receptors, peptide synthesis, pseudononapeptide analogs, tumor growth inhibition",
author = "Cai, {R. Z.} and H. Reile and P. Armatis and Schally, {Andrew V}",
year = "1994",
month = "12",
day = "20",
doi = "10.1073/pnas.91.26.12664",
language = "English",
volume = "91",
pages = "12664--12668",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "26",

}

TY - JOUR

T1 - Potent bombesin antagonists with C-terminal Leu-ψ(CH2-N)-Tac-NH2 or its derivatives

AU - Cai, R. Z.

AU - Reile, H.

AU - Armatis, P.

AU - Schally, Andrew V

PY - 1994/12/20

Y1 - 1994/12/20

N2 - Various pseudononapeptide bombesin (BN)-(6-14) antagonists with a reduced peptide bond (CH2-NH) between positions 13 and 14 can suppress the mitogenic activity of BN or gastrin-releasing peptide in 3T3 fibroblast cells and small cell lung carcinoma. In the search for more potent BN antagonists, 10 modified nonapeptide BN antagonists containing N-terminal D-Phe, D-Cpa, and D- or L-Tpi and C-terminal Leu-ψ(CH2-N)-Tac-NH2, Leu-ψ(CH2-N)-MeTac- NH2, or Leu-ψ(CH2-N)-Me2Tac-NH2 have been synthesized by incubating [13ψ14,CH2-NH,Cys14]BN-(6-14) or [13ψ14-CH2-NH,Pen14]BN-(6- 14) with formaldehyde or acetaldehyde (Cpa = 4-chlorophenylalanine, Tac = thiazolidine-4-carboxylic acid, Tpi = 2,3,4,9-tetrahydro-1H-pyrido[3,4- b]indol-3-carboxylic acid, and Pen = penicillamine). The biological activities of these compounds were then evaluated. [D-Phe6,13ψ14,CH2- N,Tac14]BN-(6-14) (RC-3950-II) and [D-Phe6,13ψ14,CH2- N,Me2Tac14]BN-(6-14) (RC-3985-II) exhibited greater potency in inhibition of 125I-labeled [Tyr4]BN binding to Swiss 3T3 cells than their parent compounds [D-Phe6,13ψ14,CH2-NH,Cys14]BN-(6-14) (RC-3950-I) and [D- Phe6,13ψ14,CH2-NH,Pen14]BN-(6-14) (RC-3985-I). The order of binding affinities of these compounds was as follows: [13ψ14,CH2-N,Tac14]BN- (6-14) > [13ψ14,CH2-N,Me2Tac14]BN-(6-14) > [13ψ14,CH2- N,MeTac14]BN-(6-14). In most cases, the analogs with C-terminal Leu- ψ(CH2-N)-Tac-NH2 were also more potent growth inhibitors of 3T3 cells than compounds containing C-terminal Leu-ψ(CH2-N)-Me2Tac-NH2 or Leu-ψ(CH2- N)-MeTac-NH2. The best BN antagonists of this series, RC-3950-II and [D- Cpa6,13ψ14,CH2-N,Tac14]BN-(6-14) (RC-3925-II), inhibited gastrin- releasing peptide-stimulated growth of Swiss 3T3 cells with IC50 values of 1 nM and 6 nM, respectively. Since antagonists of this class inhibit growth of various tumors in animal cancer models, some of them may have clinical applications.

AB - Various pseudononapeptide bombesin (BN)-(6-14) antagonists with a reduced peptide bond (CH2-NH) between positions 13 and 14 can suppress the mitogenic activity of BN or gastrin-releasing peptide in 3T3 fibroblast cells and small cell lung carcinoma. In the search for more potent BN antagonists, 10 modified nonapeptide BN antagonists containing N-terminal D-Phe, D-Cpa, and D- or L-Tpi and C-terminal Leu-ψ(CH2-N)-Tac-NH2, Leu-ψ(CH2-N)-MeTac- NH2, or Leu-ψ(CH2-N)-Me2Tac-NH2 have been synthesized by incubating [13ψ14,CH2-NH,Cys14]BN-(6-14) or [13ψ14-CH2-NH,Pen14]BN-(6- 14) with formaldehyde or acetaldehyde (Cpa = 4-chlorophenylalanine, Tac = thiazolidine-4-carboxylic acid, Tpi = 2,3,4,9-tetrahydro-1H-pyrido[3,4- b]indol-3-carboxylic acid, and Pen = penicillamine). The biological activities of these compounds were then evaluated. [D-Phe6,13ψ14,CH2- N,Tac14]BN-(6-14) (RC-3950-II) and [D-Phe6,13ψ14,CH2- N,Me2Tac14]BN-(6-14) (RC-3985-II) exhibited greater potency in inhibition of 125I-labeled [Tyr4]BN binding to Swiss 3T3 cells than their parent compounds [D-Phe6,13ψ14,CH2-NH,Cys14]BN-(6-14) (RC-3950-I) and [D- Phe6,13ψ14,CH2-NH,Pen14]BN-(6-14) (RC-3985-I). The order of binding affinities of these compounds was as follows: [13ψ14,CH2-N,Tac14]BN- (6-14) > [13ψ14,CH2-N,Me2Tac14]BN-(6-14) > [13ψ14,CH2- N,MeTac14]BN-(6-14). In most cases, the analogs with C-terminal Leu- ψ(CH2-N)-Tac-NH2 were also more potent growth inhibitors of 3T3 cells than compounds containing C-terminal Leu-ψ(CH2-N)-Me2Tac-NH2 or Leu-ψ(CH2- N)-MeTac-NH2. The best BN antagonists of this series, RC-3950-II and [D- Cpa6,13ψ14,CH2-N,Tac14]BN-(6-14) (RC-3925-II), inhibited gastrin- releasing peptide-stimulated growth of Swiss 3T3 cells with IC50 values of 1 nM and 6 nM, respectively. Since antagonists of this class inhibit growth of various tumors in animal cancer models, some of them may have clinical applications.

KW - peptide receptors

KW - peptide synthesis

KW - pseudononapeptide analogs

KW - tumor growth inhibition

UR - http://www.scopus.com/inward/record.url?scp=0028577725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028577725&partnerID=8YFLogxK

U2 - 10.1073/pnas.91.26.12664

DO - 10.1073/pnas.91.26.12664

M3 - Article

C2 - 7809097

AN - SCOPUS:0028577725

VL - 91

SP - 12664

EP - 12668

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 26

ER -